Coumarin Compounds with 6- or 7-(4-Aminobutynyloxy) Substituent: Synthesis, In Vitro Cytotoxicity and In Silico DNA Binding Studies
Molecules · 2026
DOI: 10.3390/molecules31183222 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2026. Verfasst von Anarkul S Kishkentayeva und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Karaganda Medical University, Karaganda 100012, Kazakhstan. Hauptthemen laut MEDLINE: Coumarins, DNA, Antineoplastic Agents. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
Coumarin compounds are of great interest in drug development research. Various substituents on the coumarin core significantly influence its biological activity. Although a number of coumarins with specific biological properties have already been identified, the ongoing challenge lies in the design and synthesis of novel derivatives with high specificity for pharmacological targets. In this work, 6-(4-aminobut-2-ynyloxy)- and 7-(4-aminobut-2-ynyloxy)-substituted coumarin derivatives were designed and synthesized. As a method for the synthesis of 6- or 7-substituted coumarins (yields 26–98%), a copper-catalyzed one-pot three-component reaction (A3 coupling) of 6- or 7-(prop-2-ynyloxy)coumarins with formaldehyde and secondary amines was studied. In vitro biological testing (MTT assay) results showed that the new coumarins exhibit pronounced cytotoxicity against human cervical cancer (C33 A and CaSki) and breast cancer (MCF-7) cell lines, with activity being dependent on the substituent at the nitrogen atom in the side chain. The most active compounds inhibited tumor cell growth, with GI50 values of 4.3–9.4 μM (SI = 9.1–19.8). All new compounds demonstrated low cytotoxicity against the non-malignant epithelial VERO cells (GI50 > 86 μM). To understand the observed SAR trends, molecular modeling of the interaction between the new coumarin derivatives and DNA G-quadruplex binding sites was performed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Karaganda Medical University, Karaganda 100012, Kazakhstan.
- Institute of Medicine and Medical Technologies, Novosibirsk State University, Pirogova Str., 1, 630090 Novosibirsk, Russia.
- N.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia.
- Kizhner Research Center, Tomsk Polytechnic University, 634050 Tomsk, Russia.
ORCID-Profile: Anarkul S Kishkentayeva, Andrey I Khlebnikov, Andrey G Pokrovsky, Yurii V Gatilov, Almagul S Makhmutova, Elvira E Shults
Förderung
- Russian Science Foundation
Zitieren
APA
Kishkentayeva, A. S., Hamad, M. S., Savelyev, V. A., Boyaubayeva, Z. A., Khlebnikov, A. I., Pokrovsky, A. G., Gatilov, Y. V., Makhmutova, A. S., & Shults, E. E. (2026). Coumarin Compounds with 6- or 7-(4-Aminobutynyloxy) Substituent: Synthesis, In Vitro Cytotoxicity and In Silico DNA Binding Studies. Molecules. https://doi.org/10.3390/molecules31183222
Vancouver
Kishkentayeva AS, Hamad MS, Savelyev VA, Boyaubayeva ZA, Khlebnikov AI, Pokrovsky AG, et al. Coumarin Compounds with 6- or 7-(4-Aminobutynyloxy) Substituent: Synthesis, In Vitro Cytotoxicity and In Silico DNA Binding Studies. Molecules. 2026. doi:10.3390/molecules31183222
BibTeX
@article{Kishkentayeva2026,
author = {Kishkentayeva, Anarkul S and Hamad, Mohammad S and Savelyev, Victor A and Boyaubayeva, Zhasmin A and Khlebnikov, Andrey I and Pokrovsky, Andrey G and Gatilov, Yurii V and Makhmutova, Almagul S and Shults, Elvira E},
title = {Coumarin Compounds with 6- or 7-(4-Aminobutynyloxy) Substituent: Synthesis, In Vitro Cytotoxicity and In Silico DNA Binding Studies},
journal = {Molecules},
year = {2026},
doi = {10.3390/molecules31183222}
}
EUVIMED